Introduction
Chronic lymphocytic leukemia (CLL) is an accumulative disease of small mature B lymphocytes. 1 In many patients that have progression of disease, asymptomatic peripheral blood lymphocytosis and bone marrow infiltration is followed by lymphoid organ involvement and eventually clinically significant bone marrow involvement and failure. 2 This increased accumulation of CLL cells in the bone marrow during disease progression suggests a change in the migratory and homing pattern of the cells. Abnormal cellular signaling leading to derangements in cell differentiation and survival is well recognized in CLL. 3 However, less is known regarding cellular pathways involved in cell migration. Abnormal response to integrin and chemokine signaling is suggested by the antiapoptotic effects conferred by the interactions of CXCR4 and SDF-1a, 4 as well as fibronectin and the integrin a 4 b 1 (VLA-4). These antiapoptotic effects are not induced in normal B cells. 5 The noncatalytic adaptor protein Grb7 has been related to the regulation of integrin-mediated cell migration, and to solid tumor progression and invasion. 6 Adaptor proteins function to mediate the coupling of multiple cell surface receptors to downstream signaling pathways, and thus are positioned to regulate cell signaling in a spatial and temporal way. Abnormal expression of adaptor proteins leads to significant derangements in intracellular signaling pathways and facilitates malignant processes. 7 In this paper, we show overexpression of Grb-7 in advanced stage CLL, as well as an increase in the chemokine-independent migration.
Study design
Patient population B lymphocytes were purified from the peripheral blood of five healthy controls and 60 patients with CLL between September 2001 and September 2003, in accordance with the IRB of our hospital. The diagnosis of CLL was based on the standard criteria. 2 Patients were staged according to the Rai staging system. All patients were chemotherapy naïve or at least 6 weeks after the last course of chemotherapy at the time the samples were obtained.
Cell purification
B lymphocytes were purified using RosetteSep antibody cocktail (StemCell). This method is based on negative selection of B cells. Briefly, 50 ml of a cocktail containing divalent antibodies targeted at non-B-cell antigens (CD3, CD2, CD16, CD56, CD14) was added to each milliliter of whole blood. After an incubation of 20 min, an equal amount of PBS was added to the mixture and the cells were put on a Ficoll gradient. Cells were used fresh or viably frozen in fetal calf serum (FCS) plus 10% dimethyl sulfoxide (DMSO) for storage in liquid nitrogen. Frozen cells were cultured overnight in 5% CO 2 in RPMI with 10% FCS and antibiotics.
RNA isolation and reverse transcription
Total RNA was isolated from cells using the tri-reagent kit (MRC), according to the manufacturer's instructions. Reverse transcription was carried out using Superscript II RT (Gibco-BRL).
Semiquantitative PCR analysis
The following primers were used to amplify various cDNA fragments: Grb7: forward primer -5 0 -CACCAAGGGCACCTCTCTAA GGA-3 0 , reverse primer -5 0 -TGGCCACCAGGGTATTATCTGA-3; Zap70: forward primer -5
The experimenter and at least one blinded observer assessed the level of expression of Grb7 and ZAP70. The results were in complete agreement.
Western blot analysis
Cells were lysed as described previously. 8 Lysates were separated by 12% (w/v) SDS-PAGE. The proteins were transferred onto nitrocellulose, and probed with the anti-Grb7 antibody (Santa Cruz), followed by horseradish peroxidaseconjugated goat anti rabbit IgG (Jackson).
Transwell migration
CLL cells were suspended in RPMI with 0.25% FCS. A total of 100 ml, containing 5 Â 10 6 cells, was added to the top chamber of a transwell culture insert (diameter 6.5 mm; pore 5 mm, Corning Inc, Corning, NY, USA). Filters were then transferred to wells containing 600 ml of medium with or without SDF 1a (PeproTech, Inc., Rocky Hill, NJ, USA) at a concentration of 100 ng/ml. The chambers were incubated and migration of cells to the lower chamber was analyzed by FACSort 3 h later.
Statistical analysis
Nominal parameters were analyzed using the w 2 test, and Fisher's exact test. Distribution of continuous variables was analyzed using the Kolmogorov-Smirnov test.
Results and discussion
Using semiquantitative PCR, we found a statistically significant difference in the level of mRNA expression of Grb7 between stage I and stage IV patients (Po0.001). Whereas the vast majority of patients with stage I disease (82%) had a low level of expression, most of the patients in stage IV (88%) had a high level of Grb7. (Table 1 ; Representative RT-PCR results are shown in Figure 1a .) Protein levels, as determined by Western blot analysis, followed the trend of mRNA expression (Figure 1b) . Analysis of the expression of Grb7 in a small group of stage II and III patients showed intermediate results (B60% of high expression of Grb7, Table 1 ). Within the study period, there was a significantly increased (Po0.05) disease-related mortality in patients with high Grb7 expression level (eight out of 34) compared to patients with a low expression level (one out of 26).
In parallel, we assessed the migratory properties of CLL cells in vitro, using the trans-well migration assay. We found that Stage IV cells had on average a 10-fold increase in their chemokine-independent migration as compared to stage I cells (Po0.007, Figure 1d ). Upon stimulation with SDF-1a, all cells had an increase in their migration index, in accordance with previous reports. 9 This response appeared to be more pronounced in stage I, probably because of the increased base-line migration in stage IV. As in previous studies, we found a similar level of expression of CXCR4 in the different stages of the disease 10 (results not shown). ZAP-70, a surrogate marker of the mutational state of the immunoglobulin gene, has been recently recognized as a prognostic factor and a predictor of disease progression in CLL. 11 We used semiquantitative PCR to assess the expression of ZAP70. A statistically significant correlation was found between the mRNA expression of ZAP70 and Grb7 (Po0.02). Only 13% of ZAP70-negative patients had a high level of expression of Grb7 as compared to 66% of ZAP70-positive patients (Table 2) . Interestingly, the statistical difference in the expression of Grb7, between stage I and stage IV patients, was preserved, even when examined specifically in the group of ZAP70-positive patients (Po0.01). Within the study period, a change in the Rai stage occurred in two ZAP70-positive patients. In those patients, we registered an increase in Grb7 level with disease progression (Figure 1c) .
The Rai and Binet staging systems, based on clinical parameters, have remained strong predictors of survival in CLL. Our results enable us to establish a biological correlate to the clinical staging system. The highly significant differential The expression of Grb7 also correlates with the expression of ZAP70, but, whereas ZAP70 has been shown to be a stable marker of potentially progressive disease, the statistical analysis presented above indicates that increased expression of Grb7 is related to disease progression, as we have seen directly in two of our patients. We also believe that Grb7 expression is functionally related to disease progression. Integrin signaling leads to the activation of focal adhesion kinase (FAK). Binding of FAK to Grb7 promotes cell migration, whereas binding of FAK to Grb2 promotes cell cycle progression. 12 Previous studies have shown that overexpression of Grb7 correlates with invasive properties and increased migration of solid tumor cells. 13 Our finding of an increase in the chemokine-independent spontaneous migration of stage IV cells, as compared to stage I cells, suggests that a similar mechanism may operate in CLL. This increased migration might explain the increased accumulation of CLL cells in advanced disease in the bone marrow. 9 Future studies will need to address the biological and clinical significance of these findings and the possible use of Grb7 as a marker of disease progression or a therapeutic target. 
